Clinical Trials Directory

Trials / Completed

CompletedNCT03870386

EUS Biliary Drainage vs. ERCP

EUS-guided Biliary Drainage of First Intent With the Lumen Apposing Metal Stent vs. ERCP in the Management of Malignant Distal Biliary Obstruction: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Endoscopic ultrasound guided biliary drainage (EUS-BD) is an evolving field that has grown in popularity in the management of malignant biliary obstruction. Although Endoscopic retrograde cholangio-pancreatography (ERCP) with stent insertion has been the mainstay therapy throughout several decades, the transpapillary approach through tumor tissue is associated with significant risk for adverse events such as post-ERCP pancreatitis and stent dysfunction from tumor tissue overgrowth and ingrowth. EUS-BD, through the creation of a choledochoduodenostomy with a stent, has the potential advantage of avoiding the papilla and its associated complications while potentially improving stent patency with lower risks for tumor tissue ingrowth and/or overgrowth.

Conditions

Interventions

TypeNameDescription
PROCEDUREEUS-BD with LAMSEndoscopic ultrasound guided insertion of lumen apposing metal stent forming a choledochoduodenostomy
PROCEDUREERCPEndoscopic retrograde cholangiopancreatography to localize and cannulate the bile duct using the guidewire-assisted technique.

Timeline

Start date
2019-03-08
Primary completion
2023-05-01
Completion
2023-07-01
First posted
2019-03-12
Last updated
2023-08-14

Locations

11 sites across 2 countries: Canada, France

Source: ClinicalTrials.gov record NCT03870386. Inclusion in this directory is not an endorsement.